Holliston

Holliston-based Harvard Apparatus Regenerative Technology, or HART, reported Thursday that the first quarter of 2015 saw a reduction in net loss compared with the first quarter of 2014.

Harvard Bioscience of Holliston reported a $1.4 million loss amid lower first-quarter revenues of $25.8 million, a slight drop of about 0.5 percent from $25.9 million in the same period of 2014, the life sciences manufacturer said.

The CEO at biotech firm Harvard Apparatus Regenerative Technology (HART) of Holliston has resigned, replaced on an interim basis by CFO Thomas McNaughton, the company announced.

Precision Digital of Holliston has acquired a building in nearby Hopkinton for $5.35 million

Holliston-based Harvard Apparatus Regenerative Technology, or HART, reported Thursday that the company had revenue of $45,000 in the fourth quarter of 2014 from the sale of bioreactor systems for organ regeneration research. That was more than double the $22,000 in revenue for the same period in 2013.

Harvard Bioscience of Holliston reported record quarterly revenues of $30.4 million in the fourth quarter of 2014.

Biotech firm Harvard Apparatus Regenerative Technology of Holliston has closed a previously announced public stock offering after raising about $8.6 million, the company announced this week.

Harvard Bioscience of Holliston has acquired HEKA Electronik, a privately held, Germany-based biomedical instrumentation and software business. The acquisition was for approximately $6 million in cash, Harvard Bioscience announced Thursday.

Who are some of the organizations in Central Massachusetts that do good things for their employees? In this, the third consecutive year in which we've honored them, we shine the spotlight on nine.

Holliston-based construction firm Colantonio Inc. develops employees like it builds structures: from the ground up.Company President Francis...